🧠 New Insights from Pharmidex: Tumour Microdialysis in Glioblastoma
July 10, 2025

We’re excited to share our latest work on tumour microdialysis, a powerful technique for measuring unbound, pharmacologically active drug concentrations directly within brain tumours like glioblastoma.


Unlike systemic plasma levels, microdialysis provides a true picture of drug penetration into the tumour helping to uncover heterogeneous distribution and the impact of the blood-tumour barrier.


Our approach involves precise stereotaxic surgery, tumour validation, and sampling from both tumour and healthy brain tissue enabling direct, comparative pharmacokinetic analysis.


📊 The results? Significant differences in drug exposure between tumour core and surrounding tissue.


👉 Swipe through the carousel to explore our process and findings.



🔗 www.pharmidex.com

New Insights from Pharmidex: Tumour Microdialysis in Glioblastoma
New Insights from Pharmidex: Tumour Microdialysis in Glioblastoma

The body content of your post goes here. To edit this text, click on it and delete this default text and start typing your own or paste your own from a different source.

Pharmidex at ON Helix 2025
July 2, 2025
We’re excited that Ash Alavijeh (Head of Operations) and Ian Knowles (Head of Respiratory) will attend ON Helix 2025 on 3 July in Cambridge, UK .  They look forward to meeting fellow attendees and exploring new ways to collaborate in drug discovery and development . 📍 https://www.onhelix.com
Milner Therapeutics Symposium 2025
June 30, 2025
We’re excited that Ash Alavijeh (Head of Operations) and Janette Robertson (Business Development Manager) will attend the Milner Therapeutics Symposium on 30 June 2025 in Cambridge.  They look forward to connecting with attendees and discussing how Pharmidex can support collaboration and innovation in drug discovery. 📍 https://milner.glueup.com/event/milner-therapeutics-symposium-2025-132179/home.html
June 27, 2025
At Pharmidex our CNS team are specialists in microdialysis, with over 30 years of experience in the technique.  Our team combines the technique with powerful analytical techniques, allowing us to measure 13 different analytes in addition to test compounds in each sample. This method allows for detailed Pharmacokinetic and Pharmacodynamic profiling. 🎯 Dual probe or single probe | 🔬 Murine models | ⏳ Real-time PK/PD Ready to add this to your CNS programme? Let's talk.
More Posts